Home Cart 0 Sign in  
X

[ CAS No. 881668-70-8 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 881668-70-8
Chemical Structure| 881668-70-8
Chemical Structure| 881668-70-8
Structure of 881668-70-8 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 881668-70-8 ]

Related Doc. of [ 881668-70-8 ]

Alternatived Products of [ 881668-70-8 ]

Product Details of [ 881668-70-8 ]

CAS No. :881668-70-8 MDL No. :MFCD09608056
Formula : C4H3ClN2O2 Boiling Point : -
Linear Structure Formula :- InChI Key :MOTPCOWWOZSEHC-UHFFFAOYSA-N
M.W : 146.53 Pubchem ID :44607726
Synonyms :

Calculated chemistry of [ 881668-70-8 ]

Physicochemical Properties

Num. heavy atoms : 9
Num. arom. heavy atoms : 5
Fraction Csp3 : 0.0
Num. rotatable bonds : 1
Num. H-bond acceptors : 3.0
Num. H-bond donors : 2.0
Molar Refractivity : 30.56
TPSA : 65.98 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.46 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.25
Log Po/w (XLOGP3) : 1.04
Log Po/w (WLOGP) : 0.76
Log Po/w (MLOGP) : -0.13
Log Po/w (SILICOS-IT) : 1.11
Consensus Log Po/w : 0.61

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 2.0
Bioavailability Score : 0.56

Water Solubility

Log S (ESOL) : -1.75
Solubility : 2.61 mg/ml ; 0.0178 mol/l
Class : Very soluble
Log S (Ali) : -2.02
Solubility : 1.41 mg/ml ; 0.00964 mol/l
Class : Soluble
Log S (SILICOS-IT) : -1.2
Solubility : 9.18 mg/ml ; 0.0627 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.61

Safety of [ 881668-70-8 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P280-P305+P351+P338-P310 UN#:N/A
Hazard Statements:H302-H315-H319-H332-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 881668-70-8 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 881668-70-8 ]
  • Downstream synthetic route of [ 881668-70-8 ]

[ 881668-70-8 ] Synthesis Path-Upstream   1~1

  • 1
  • [ 15953-45-4 ]
  • [ 881668-70-8 ]
YieldReaction ConditionsOperation in experiment
80%
Stage #1: With potassium permanganate In water; <i>tert</i>-butyl alcohol at 70℃;
Stage #2: With hydrogenchloride In water; <i>tert</i>-butyl alcohol
S-Chloropyrazole-S-carboxylic acid (IV) A solution of KMnO4 (3.5 g, 22 mmol) in water (120 mL) was added in portions over a period of 5 h at 7O0C to a solution of 5-chloro-3-methylpyrazle (1.0 g, 8.8 mmol; see Intermediate (III) above) in water (50 mL) and fenr-butanol (1 mL). The mixture was stirred at 7O0C overnight and filtered through Celite.(R).. The colourless filtrate was concentrated and acidified with HCl (aq., 2M). Filtration gave the title compound as a white powder which was used without further purification. (Yield: 913 mg5 80percent). 1H-NMR (DMSO-d6): δ 6.80 (s, IH)5 4.40 (br s, IH).
67% With potassium permanganate In water; <i>tert</i>-butyl alcohol at 70 - 75℃; (b) S-Chloropyrazole-S-carboxylic acidA mixture of 5-chloro-3-methylpyrazole (3.6 mmol; see step (a) above), water (6 mL) and tert-bvttanol (1.2 mL) was heated to 750C5 after which KMnO4 (1.42 g, 9 mmol) was added. The mixture was stirred at 750C overnight and filtered hot. The solids were washed with boiling water. The combined cooled filtrates were extracted with EtOAc5 and the combined extracts washed with NaCl (sat., aq.), dried (MgSO4) and concentrated. The crude solid was recrystallised from EtOAc/hexane/pentane to give the sub-title compound as white crystals (Yield: 350 mg (67percent)). 1H-NMR (DMSO-d6, 400 MHz)5 δ 13.65 (br s, IH)5 6.80 (s, IH). (d) S-Chloropyrazole-S-carboxylic acidA solution of KMnO4 (3.5 g, 22 mmol) in water (120 mL) was added in portions over a period of 5 h at 7O0C to a solution of 5-chloro-3 -methylpyrazole (1.0 g, 8.8 mmol; see step (c) above) in water (50 mL) and tert-butanol (1 mL). The mixture was stirred at 7O0C overnight and filtered through Celite.(R).. The colourless filtrate was concentrated and acidified with HCl (aq., 2M). Filtration gave the title compound as a white powder which was used without further purification. (Yield: 913 mg, 80percent). 1H-NMR (DMSO-d6): δ 6.80 (s, IH), 4.40 (br s, IH).
67% With potassium permanganate In water; <i>tert</i>-butyl alcohol at 75℃; (b) S-Chloropyrazole-S-carboxylic acidA mixture of 5-chloro-3-methylpyrazole (3.6 mmol; see step (a) above), water (6 mL) and fert-butanol (1.2 mL) was heated to 750C, after which KMnO4 (1.42 g, 9 mmol) was added. The mixture was stirred at 75° C overnight and filtered hot. The solids were washed with boiling water. The combined cooled filtrates were extracted with EtOAc, and the combined extracts washed with NaCl (sat., aq.), dried (MgSO4) and concentrated. The crude solid was recrystallised from EPO <DP n="53"/>EtOAc/hexane/pentane to give the sub-title compound as white crystals (Yield:350 mg (67percent)).1H-NMR (DMSO-d6, 400 MHz), δ 13.65 (br s, IH), 6.80 (s, IH)
67% With potassium permanganate; <i>tert</i>-butyl alcohol In water at 70 - 75℃; A solution ofKMnC>4 (3.5 g, 22 mmol) in water (120 mL) was added in portions over aperiod of 5 h at 70 C to a solution of5-chloro-3-methylpyrazole (1.0 g, 8.8 mmol; see step (c) above) in water (50 mL) and fc/^-butanol (1 mL). The mixture was stirred at 70 C overnight and filtered through Celite.(R).. The colourless filtrate was concentrated and acidified with HC1 (2M). Filtration gave the title compound as a white powder which was used without further purification. (Yield: 913 mg, 80percent). ^-NMR (DMSO-dg): 5 13.65 (br s, 1H), 6.80 (s, 1H), 4.40 (bs, 1H).; A mixture of5-chloro-3-methylpyrazole (3.6 mmol; see step (a) above), water (6 mL), /e/Y-butanol (1.2 mL) and KMn04 (1.42 g, 9 mmol) was stirred at 75 C overnight. The hot mixture was filtered and the solids washed with boiling water. The combined filtrates were extracted twice with EtOAc. The combined extracts were washed with Nad (aq, sat), dried (MgS04) and concentrated to provide a solid, which was crystallised from EtOAc/hexane/pentane to give the sub-title product as white crystals (Yield: 350 mg (67percent)). 'H-NMR (DMSO-dg, 400 MHz), 5 13.65 (br s, 1H), 6.80 (s, 1H), 4.40 (bs, 1H).
67% With potassium permanganate In water; <i>tert</i>-butyl alcohol at 70 - 75℃; (b) 5-Chloropyrazole-3-carboxylic acid..A mixture of 5-chloro-3-methylpyrazole (3.6 mmol; see step (a) above), water (6 mL) and terf-butanol (1.2 mL) was heated to 750C, after which KMnO4 (1.42 g, 9 mmol) was added. The mixture was stirred at 75°C overnight and filtered hot. The solids were washed with boiling water. The combined cooled filtrates were extracted with EtOAc, and the combined extracts washed with NaCI (sat., aq.), dried (MgSO4) and concentrated. The crude solid was recrystallised from EtOAc/hexane/pentane to give the sub-title compound as white crystals (Yield: 350 mg (67percent)). 1H-NMR (DMSO-d6, 400 MHz), δ 13.65 (br s, 1 H), 6.80 (s, 1 H). (d) 5-Chloropyrazole-3-carboxylic acid. A solution of KMnO4 (3.5 g, 22 mmol) in water (120 mL) was added in portions over a period of 5 h at 700C to a solution of 5-chloro-3-methylpyrazole (1.0 g, 8.8 mmol; see step (c) above) in water (50 mL) and terf-butanol (1 mL). The mixture was stirred at 7O0C overnight and filtered through Celite.(R).. The colourless filtrate was concentrated and acidified with HCI (aq., 2M). Filtration gave the title compound as a white powder which was used without further purification. (Yield: 913 mg, 80percent). 1H-NMR (DMSO-d6): δ 6.80 (s, 1 H), 4.40 (br s, 1 H).

Reference: [1] Patent: WO2007/45868, 2007, A1, . Location in patent: Page/Page column 43
[2] Patent: WO2007/51981, 2007, A1, . Location in patent: Page/Page column 48; 49
[3] Patent: WO2007/45868, 2007, A1, . Location in patent: Page/Page column 50-51
[4] Patent: WO2006/32851, 2006, A1, . Location in patent: Page/Page column 41; 42
[5] Patent: WO2008/129280, 2008, A1, . Location in patent: Page/Page column 46-47
[6] Bioorganic and Medicinal Chemistry Letters, 2015, vol. 25, # 15, p. 3024 - 3029
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 881668-70-8 ]

Chlorides

Chemical Structure| 1172229-72-9

[ 1172229-72-9 ]

Ethyl 5-chloro-1-methyl-1H-pyrazole-3-carboxylate

Similarity: 0.78

Chemical Structure| 15953-45-4

[ 15953-45-4 ]

5-Chloro-3-methyl-1H-pyrazole

Similarity: 0.70

Chemical Structure| 1005584-90-6

[ 1005584-90-6 ]

Methyl 4-chloro-1H-pyrazole-3-carboxylate

Similarity: 0.64

Chemical Structure| 1077-95-8

[ 1077-95-8 ]

5-Chloro-1H-indazole-3-carboxylic acid

Similarity: 0.62

Chemical Structure| 54006-63-2

[ 54006-63-2 ]

5-(4-Chlorophenyl)-1H-pyrazole-3-carboxylic acid

Similarity: 0.61

Carboxylic Acids

Chemical Structure| 1621-91-6

[ 1621-91-6 ]

1H-Pyrazole-3-carboxylic acid

Similarity: 0.81

Chemical Structure| 25016-20-0

[ 25016-20-0 ]

1-Methyl-1H-pyrazole-3-carboxylic acid

Similarity: 0.74

Chemical Structure| 402-61-9

[ 402-61-9 ]

5-Methyl-1H-pyrazole-3-carboxylic acid

Similarity: 0.72

Chemical Structure| 82231-51-4

[ 82231-51-4 ]

4-Methylpyrazole-3-carboxylic Acid

Similarity: 0.72

Chemical Structure| 89603-60-1

[ 89603-60-1 ]

5-Hydroxy-1H-pyrazole-3-carboxylic acid

Similarity: 0.71

Related Parent Nucleus of
[ 881668-70-8 ]

Pyrazoles

Chemical Structure| 1621-91-6

[ 1621-91-6 ]

1H-Pyrazole-3-carboxylic acid

Similarity: 0.81

Chemical Structure| 1172229-72-9

[ 1172229-72-9 ]

Ethyl 5-chloro-1-methyl-1H-pyrazole-3-carboxylate

Similarity: 0.78

Chemical Structure| 25016-20-0

[ 25016-20-0 ]

1-Methyl-1H-pyrazole-3-carboxylic acid

Similarity: 0.74

Chemical Structure| 15366-34-4

[ 15366-34-4 ]

Methyl 1H-pyrazole-3-carboxylate

Similarity: 0.73

Chemical Structure| 402-61-9

[ 402-61-9 ]

5-Methyl-1H-pyrazole-3-carboxylic acid

Similarity: 0.72